A Study to Evaluate the Long-term Impact of Natalizumab Treatment Continuation or Discontinuation on EDSS in Patients With Multiple Sclerosis (MS)
Latest Information Update: 25 Feb 2016
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 25 Feb 2016 New trial record